Professor Andrew Lew

Professor Andrew Lew



Andrew Lew



BVSc(Hons) MVSc Melbourne PhD London

Laboratory Head


Lab focus: diabetes, autoimmunity and transplantation

My lab is developing new strategies to target local immune responses. This has the potential to improve islet transplantation as a cure for type 1 diabetes.

We are also developing new strategies to improve or dampen immune responses. These have many potential applications, including improving vaccination, and treating autoimmunity.

Research interest

We are developing new strategies to modulate immune responses for improved health outcomes.

A particular focus is on improving islet transplantation as a cure for type 1 diabetes. Currently this requires the use of dangerous immunosuppressive drugs for the transplant to be accepted. We are investigating strategies to reduce the need for systemic immunosuppression.

We are also studying how to control the survival of dendritic cells and T cells. Our goal is to use this to tailor therapies to improve the outcomes for transplantation, vaccination, and treatment of autoimmune diseases. 


Scientists looking at a vial in a laboratory

An institute team has developed a molecule that can halt inflammation and has shown promise in preventing the progression of multiple sclerosis.